ALGS
Aligos Therapeutics, Inc.
$6.62
-0.15 (-2.22%)
At close · Jul 10
Market Cap
$23.75M
Shares
3,587,892
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-25 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-25 | |
| 8-K | 2026-04-21 | 2026-04-16 | |
| 8-K | 2026-04-14 | — | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-02-04 | 2026-01-29 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-26 | 2025-06-25 | |
| 8-K | 2025-05-06 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2025-06-25 | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-02-12 | 2025-02-11 | |
| 8-K | 2025-02-03 | 2025-01-30 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-09-05 | 2024-09-03 | |
| 8-K | 2024-08-19 | 2024-08-14 | |
| 8-K | 2024-08-08 | 2024-08-07 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-28 | 2024-06-27 | |
| 8-K | 2024-05-31 | 2024-05-29 | |
| 8-K | 2024-05-22 | 2024-05-21 | |
| 8-K | 2024-05-15 | 2024-05-09 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-29 | 2024-06-27 | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2024-03-12 | — | |
| 8-K | 2024-02-28 | 2024-02-27 | |
| 8-K | 2024-01-25 | — | |
| 8-K | 2023-11-22 | 2023-11-20 | |
| 8-K | 2023-11-15 | 2023-11-09 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-10-25 | 2023-10-23 | |
| 8-K | 2023-10-18 | 2023-10-16 | |
| 8-K | 2023-09-07 | 2023-09-05 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-08-01 | 2023-07-31 | |
| 8-K | 2023-07-25 | 2023-07-20 |
Showing 1–50 of 83 filings